Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
INP30
- Development stage
- Unknown
- Lead developer
- InnoUp Farma
- Modality
- Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
INP30 is an oral prophylactic vaccine candidate for COVID-19 developed by InnoUp Farma in collaboration with the University of Navarra. The vaccine utilizes a proprietary nanotechnology platform that employs biocompatible nanoparticles with high bio-adhesive properties to the intestinal mucosa. This delivery system is designed to encapsulate vaccine antigens, protecting them from degradation in the gastrointestinal tract and enabling their delivery to the mucosal immune system. By targeting the gut-associated lymphoid tissue, INP30 aims to induce both systemic and mucosal immunity against SARS-CoV-2. The platform is versatile, capable of carrying protein, RNA, or DNA payloads, though INP30 is specifically focused on SARS-CoV-2 prevention and has advanced into Phase 1/2 clinical development.
- Other names
- Oral SARS-CoV-2 vaccine (InnoUp Farma)
Beyond the preview
Go deeper on INP30.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on INP30.